Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University’s LIFE project has launched a new set of app-based training scenarios that help healthcare workers in Africa safely manage and treat cases of children with suspected COVID-19

Nurse wearing a face mask

Life-saving Instruction for Emergencies (LIFE) is a smartphone-based virtual learning platform that allows healthcare workers to access high quality medical training in low-resource settings. Developed by doctors, nurses and researchers at the KEMRI-Wellcome Trust Research Programme (KWTRP) in Kenya and the University of Oxford, the platform has now launched new training scenarios to help healthcare workers in Africa safely deliver care to children with suspected COVID-19.

LIFE allows healthcare workers to enter a realistic 3D virtual hospital on their own smartphones, allowing them to train anywhere, anytime. In low-resource settings such as Kenya, access to simulation training can be difficult and expensive, so using their own smartphones to train could enable more healthcare workers to receive the high-quality training they need to save lives.

Neonatal resuscitation training delivered through the LIFE smartphone app has been rolled out to more than 5,000 healthcare workers through partnerships with medical and nursing schools and professional organisations such as the Kenya Paediatric Association and the Nursing Council of Kenya. This new update to the LIFE app adds three new training scenarios on the management of children with suspected covid-19.

Conrad Wanyama, a nurse from the KEMRI-Wellcome Trust Research Programme who led the development of the covid-19 clinical content, said:

"We have used official WHO guidance to develop a highly engaging training app for healthcare workers in Africa. The covid-19 scenarios use 3D animations and videos to show how to follow correct infection control procedures to safely and effectively manage children who are suspected of having covid-19."

Dr Chris Paton, the lead researcher for LIFE from the University of Oxford, commented:

“Smartphones are now very commonly used by healthcare workers in Africa. After downloading the app for free to their phones, healthcare workers can now train anywhere that is convenient and learn the key steps they need to know to save lives in emergencies.”

Tuti Ng’ang’a, a DPhil student at the University of Oxford, studied the effect of LIFE on healthcare workers’ learning gains. He said:

“There is a considerable learning gain between the first two rounds of learning for healthcare workers that use the LIFE app. My research showed that new approaches to adaptive feedback linked to how healthcare workers spaced their learning could improve learning gains further.”

 

Life-saving Instruction for Emergences (LIFE) is a virtual reality and smartphone app delivering medical training through mobile and VR platforms. The platform was initially developed by clinicians and researchers at the KEMRI-Wellcome Trust Research Programme and the University of Oxford, and its development has been supported by HTC, Oxford University Innovation, GCRF, the Bill and Melinda Gates Foundation, the Wellcome Trust, Saving Lives at Birth and Médecins Sans Frontières.

LIFE is available to download for free for smartphones or search for “Life-saving Instruction for Emergencies” on the Google Play Store.

Follow the LIFE project on twitter @OxLIFEproject

Similar stories

Arjen Dondorp, Peter Horby and Rose McGready elected Academy of Medical Sciences Fellows

Awards & Appointments MORU OCGHR

"Although it is hard to look beyond the pandemic right now," says President of the Academy of Medical Sciences Professor Dame Anne Johnson, "I want to stress how important it is that the Academy Fellowship represents the widest diversity of biomedical and health sciences. The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration."

We gathered rich insights into child survival in Kenya by mapping patterns over 22 years

KWTRP Research

Although improvements in child survival globally have been remarkable, 5.2 million children still died in 2019, over half of these in sub-Saharan Africa. A range of factors likely include disparities in childhood immunisations, supplements and breastfeeding practices, antenatal care, skilled birth attendants working in healthcare facilities. Kenya needs to prioritise its child care plans, based on localities and populations with the greatest need. Two KWTRP studies give granular insights into the situation in regions across Kenya.

What it takes to reach zero malaria

KWTRP

Interview with KWTRP Malaria immunologist Dr Francis Ndungu. Francis grew up in central Kenya where malaria is not prevalent but is interested in understanding of how semi-immune individuals control malaria parasite growth and the associated inflammation symptoms. His current work is in understanding how we develop immunity to Malaria. He is also interested in the potential translation of that knowledge in the development of effective malaria vaccines.

Celebrating women in ICT: connected girls, creating brighter futures

KWTRP Public Engagement

The International Girl’s in ICT day is commemorated to create awareness on the critical need for more girls and women in the ICT sector, encourage and inspire young girls to actively pursue careers in STEM as well as engage the community to promote collaboration through partnerships. Kathreen Wafula, an ICT Support Technician in Kilifi, joins a strong team of techies and is one of the 4 women in the department.

Risks of serious adverse events following treatment for visceral leishmaniasis

OCGHR Publication Research

This large-scale systematic review and meta-analysis aimed to collate all reported serious adverse events in visceral leishmaniasis clinical trials and quantify the incidence of mortality during the first 30 days of therapy. The analyses, which included clinical data from more than 35,000 patients, found that mortality following treatment was an extremely rare event and serious adverse events following treatments were poorly reported.

The RECOVERY Trial: One year on

OCGHR Research

The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial was officially launched on 23 March 2020. It is the world's largest COVID-19 drug trial. Thanks to the ground-breaking work of RECOVERY, clinicians treating patients hospitalised with severe COVID-19 now have two treatments that are known to improve survival.